Point: It's never too soon.
A multidisciplinary approach to prostate cancer has become the rule and not the exception. Involving the entire team, which includes a medical oncologist, from the time of initial diagnosis is optimal. This facilitates maximal patient education regarding treatment options and enhances informed decision making. A coordinated approach also promotes enrollment on clinical trials, which are often, multimodality, especially in high-risk early stage prostate cancer. Integrated therapeutic strategies throughout the patient's disease course can improve both patient care and satisfaction
Dawson
Nancy A
NA
University of Maryland Greenebaum Cancer Center, School of Medicine, Baltimore, Maryland, USA.
D006801:Humans; D008297:Male; D010348:Patient Care Team; D011471:Prostatic Neoplasms / Q000628:therapy*; D013997:Time Factors